This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Retrospective Study on the Evaluation of Intra-disc Infiltration in the Active Disc Disease

Sponsored by Fondation Hôpital Saint-Joseph

About this trial

Last updated 9 years ago

Study ID

MODIC

Status

Withdrawn

Type

Observational

Placebo

No

Accepting

18+ Years
All Sexes

Trial Timing

Ended 11 years ago

What is this trial about?

Active discopathies or MODIC 1, are a diagnostic entity discovery with the contribution of MRI in which the first cases were described by Dr. Michael MODIC in 1988. It is characterized by a vertebral bone edema secondary to active discarthrose. Its prevalence is estimated at 6% of the general population and up to 40% of the CLBP according to studies. Following the discovery of this recent diagnostic entity, responsible for low back pain, the question of its management is debate in the medical community. Early studies demonstrate the effectiveness of corticosteroid injections in intra-disc. Other works, most recent, suggest the contrary, infectious, incriminating a pathogenic role of certain bacteria such as Propionibacterium acness or Corynebacterium propinquum recommending, in contrast, treatment with prolonged antibiotic therapy. This study will aim to assess the effectiveness of intra-disc infiltration GHPSJ carried out between 2007 and 2014. The innovation of our work will be to assess these infiltrations in various subgroups such as patients with a previous surgery of the spine or a history of scoliosis or spondylolisthesis.

What are the participation requirements?

Inclusion Criteria

* Patient aged > 18yo

* Hospitalization between 2007 and 2014 in the Rheumatology Department for intradiscal infiltration

Exclusion Criteria

* None